Citi Pharma Limited (PSX:CPHL)
75.08
-0.66 (-0.87%)
At close: Aug 7, 2026
-10.74% (1Y)
| Market Cap | 17.15B -10.7% |
| Revenue (ttm) | 13.84B +6.7% |
| Net Income | 1.10B +32.0% |
| EPS | 4.80 +31.9% |
| Shares Out | 228.46M |
| PE Ratio | 15.64 |
| Forward PE | n/a |
| Dividend | 3.50 (4.66%) |
| Ex-Dividend Date | Oct 17, 2025 |
| Volume | 730,209 |
| Open | 75.50 |
| Previous Close | 75.74 |
| Day's Range | 74.75 - 76.12 |
| 52-Week Range | 69.25 - 104.25 |
| Beta | 0.43 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 2, 2026 |